Introduction:Basic information about CAS 17692-31-8|Dropropizine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Dropropizine is a racemic non-opiate antitussive agent which has been used clinically for many years.
Related Catalog
Signaling Pathways >>Others >>OthersResearch Areas >>Inflammation/Immunology
Chemical & Physical Properties
Density
1.2±0.1 g/cm3
Boiling Point
412.7±34.0 °C at 760 mmHg
Melting Point
105-108ºC
Molecular Formula
C13H20N2O2
Molecular Weight
236.310
Flash Point
220.9±24.3 °C
Exact Mass
236.152481
PSA
46.94000
LogP
0.46
Vapour Pressure
0.0±1.0 mmHg at 25°C
Index of Refraction
1.577
InChIKey
PTVWPYVOOKLBCG-UHFFFAOYSA-N
SMILES
OCC(O)CN1CCN(c2ccccc2)CC1
Toxicological Information
CHEMICAL IDENTIFICATION
RTECS NUMBER :
TZ1074800
CHEMICAL NAME :
1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-
CAS REGISTRY NUMBER :
17692-31-8
LAST UPDATED :
199712
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C13-H20-N2-O2
MOLECULAR WEIGHT :
236.35
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
750 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3163649
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #3163649
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
620 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4372958
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
720 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4372958
Safety Information
Symbol
GHS07
Signal Word
Warning
Hazard Statements
H302
Personal Protective Equipment
dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes
Xn:Harmful;
Risk Phrases
R22
Safety Phrases
S36
RIDADR
NONH for all modes of transport
WGK Germany
3
RTECS
TZ1074800
HS Code
2933599090
Customs
HS Code
2933599090
Summary
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles25
More Articles
Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough.
J. Int. Med. Res. 23(3) , 175-83, (1995)
The antitussive efficacy and tolerability of dropropizine and of its enantiomer levodropropizine were evaluated in children with non-productive cough; 258 were evaluable for tolerability and 254 for e...
Efficacy of levodropropizine in pediatric cough.
Pulm. Pharmacol. Ther. 25(5) , 337-42, (2012)
Cough in children is among the most common problems managed by pediatricians, and occurs more frequently in preschool than in older children. Most acute episodes of cough are due to viral upper respir...
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.
Ther. Drug Monit. 26(4) , 441-9, (2004)
Studies are described on the metabolism and the toxicologic analysis of the nonopioid cough suppressant dropropizine [R,S-3-(4-phenyl-1-piperazinyl)1,2-propandiol, DRO] in human urine using gas chroma...